221 related articles for article (PubMed ID: 14690635)
1. Idiosyncratic toxicity: the role of toxicophores and bioactivation.
Williams DP; Park BK
Drug Discov Today; 2003 Nov; 8(22):1044-50. PubMed ID: 14690635
[TBL] [Abstract][Full Text] [Related]
2. Minimising the potential for metabolic activation in drug discovery.
Kalgutkar AS; Soglia JR
Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):91-142. PubMed ID: 16922655
[TBL] [Abstract][Full Text] [Related]
3. Toxicophores: investigations in drug safety.
Williams DP
Toxicology; 2006 Sep; 226(1):1-11. PubMed ID: 16860917
[TBL] [Abstract][Full Text] [Related]
4. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity.
Park BK; Laverty H; Srivastava A; Antoine DJ; Naisbitt D; Williams DP
Chem Biol Interact; 2011 Jun; 192(1-2):30-6. PubMed ID: 20846520
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of drug toxicity and relevance to pharmaceutical development.
Guengerich FP
Drug Metab Pharmacokinet; 2011; 26(1):3-14. PubMed ID: 20978361
[TBL] [Abstract][Full Text] [Related]
6. Are chemically reactive metabolites responsible for adverse reactions to drugs?
Williams DP; Kitteringham NR; Naisbitt DJ; Pirmohamed M; Smith DA; Park BK
Curr Drug Metab; 2002 Aug; 3(4):351-66. PubMed ID: 12093355
[TBL] [Abstract][Full Text] [Related]
7. Drug bioactivation, covalent binding to target proteins and toxicity relevance.
Zhou S; Chan E; Duan W; Huang M; Chen YZ
Drug Metab Rev; 2005; 37(1):41-213. PubMed ID: 15747500
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation in drug allergies.
Park BK; Naisbitt DJ; Gordon SF; Kitteringham NR; Pirmohamed M
Toxicology; 2001 Feb; 158(1-2):11-23. PubMed ID: 11164988
[TBL] [Abstract][Full Text] [Related]
9. The role of reactive drug metabolites in immune-mediated adverse drug reactions.
Hess DA; Rieder MJ
Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694
[TBL] [Abstract][Full Text] [Related]
10. Structural alerts, reactive metabolites, and protein covalent binding: how reliable are these attributes as predictors of drug toxicity?
Kalgutkar AS; Didiuk MT
Chem Biodivers; 2009 Nov; 6(11):2115-37. PubMed ID: 19937848
[TBL] [Abstract][Full Text] [Related]
11. Metabolic activation in drug-induced liver injury.
Leung L; Kalgutkar AS; Obach RS
Drug Metab Rev; 2012 Feb; 44(1):18-33. PubMed ID: 21939431
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450s and other enzymes in drug metabolism and toxicity.
Guengerich FP
AAPS J; 2006 Mar; 8(1):E101-11. PubMed ID: 16584116
[TBL] [Abstract][Full Text] [Related]
13. Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?
Kalgutkar AS; Fate G; Didiuk MT; Bauman J
Expert Rev Clin Pharmacol; 2008 Jul; 1(4):515-31. PubMed ID: 24410554
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics in drug intolerance.
Andreu I; Mayorga C; Miranda MA
Curr Drug Metab; 2009 Nov; 10(9):947-55. PubMed ID: 20214587
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system.
Ju C; Uetrecht JP
Curr Drug Metab; 2002 Aug; 3(4):367-77. PubMed ID: 12093356
[TBL] [Abstract][Full Text] [Related]
16. Role of bioactivation in drug-induced hypersensitivity reactions.
Sanderson JP; Naisbitt DJ; Park BK
AAPS J; 2006 Feb; 8(1):E55-64. PubMed ID: 16584134
[TBL] [Abstract][Full Text] [Related]
17. Detecting reactive drug metabolites for reducing the potential for drug toxicity.
Grillo MP
Expert Opin Drug Metab Toxicol; 2015; 11(8):1281-302. PubMed ID: 26005795
[TBL] [Abstract][Full Text] [Related]
18. Drug metabolite profiling and elucidation of drug-induced hepatotoxicity.
Tang W
Expert Opin Drug Metab Toxicol; 2007 Jun; 3(3):407-20. PubMed ID: 17539747
[TBL] [Abstract][Full Text] [Related]
19. Selection of new chemical entities with decreased potential for adverse drug reactions.
Park KB; Dalton-Brown E; Hirst C; Williams DP
Eur J Pharmacol; 2006 Nov; 549(1-3):1-8. PubMed ID: 16979156
[TBL] [Abstract][Full Text] [Related]
20. Predicting toxicities of reactive metabolite-positive drug candidates.
Kalgutkar AS; Dalvie D
Annu Rev Pharmacol Toxicol; 2015; 55():35-54. PubMed ID: 25292426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
